Abstract CT133: A phase 1b multicenter study of anti-TIM3 (S095018/Sym023) in combination with anti-PD1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer
Ghiringhelli, Francois, Kim, Richard, Macarulla, Teresa, Moreno, Irene, Razak, Albiruni, Rodon, Jordi, Liao, Chih-Yi, Marron, Thomas, Raimbourg, Judith, Kaplon, Helene, Geromini, Julia, Harouki, Najah, Rodrigues, Christelle, Darcel, Pauline, Skartved, Niels Jorgen, Hald, Rikke, Lopez-Ravnborg, Daleen, He, Peng, Ianopoulos, Xenophon, Askoxylakis, Vasileios, Lakhani, Nehal J., Davis, Sarah, Mahipal, Amit
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article